Call for Board of Directors Interested in driving the direction of AMCP's mission? Join the Board of Directors! Apply Now Close
  • Value-Based Care Lexicon

    Talking the Talk. In the World of Value-Based Care, Words Matter: A Lexicon for Value-Based Purchasing

    Explore the lexicon and additional value-based contracts resources in the AMCP Resource Center.

    Learn More

  • Major Depressive Disorder

    NEW: Major Depressive Disorder Resource Center

    Depression affects how you feel, think, and behave and can lead to a variety of emotional and physical problems. Find the latest therapies and research on our Major Depressive Disorder Resources page.

    Learn More

  • Nexus 2022

    Secure Your Spot at AMCP Nexus 2022 Today!

    Don’t miss your chance to attend Nexus 2022! Join more than 2,500 managed care leaders as we envision, ignite, and steer the future of public health — lowest rates available until July 20!

    Register Today

  • Drug Product Pipeline

    Visit the AMCP Drug Product Pipeline!

    Gain insight into tomorrow's medications, treatments, and cures.

    Learn More

  • State Advocacy Leader Program

    New Member Benefit: Interactive Policy Map

    Stay up-to-date on the latest state legislation monitored by AMCP.

    View Map

Jen G Guest blog
Value-Based Care

Are We There Yet? Incorporating Value in Coverage Decisions

In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
By Jennifer Graff, PharmD  7/26/22

Disease State Resources

Get in-depth information and explore up-to-date resources about pressing disease states in AMCP’s Disease State Resource Center. AMCP is pleased to work with leading pharmaceutical companies to offer these timely resources to you.
3/9/22

Pharmacoequity: A New Opportunity for Managed Care Pharmacy

In this guest blog post, Tenicia Talley, PharmD, MSCR, discussespharmacoequity and how this applies to AMCP's efforts in addressing racial health disparities.
By Tenicia Talley, PharmD, MSCR 3/1/22
Icon - People Delivering Webinar on Computer - With White Background

Managed Care Decision-Makers

Looking for easy access to current product information, dossiers, and other resources to help you in formulary development? FormularyDecisions has the tools you need – all in one place!

Register Today
Icon - Person leaning on light bulb - with white behind

AMCP Foundation – Investing in the Future

AMCP Foundation supports managed care research and cultivates tomorrow's leaders. Join us to advance insights for a healthier future.

Learn More

Grow Your
Network through AMCP

8,000
Members waiting
for you to join them
As an AMCP member, you are connected to thousands of other members working for health plans, PBMs, and others who work to support and inform managed care pharmacy. Connect with fellow members today!
AMCP member
AMCP member
AMCP member
AMCP member
Join today and get started

The Latest

AMCP Logo

AMCP Statement on the Passage of the Inflation Reduction Act

On August 12, the House of Representatives voted to approve the Senate-passed Inflation Reduction Act, containing significant health policy reforms.

8/12/22
AMCP Logo

2022-2023 Diplomat Fall Kick-Off Webinar

The School of Pharmacy Relations Committee (SOPRC) hosted a call to give an overview of the Diplomat program.

8/11/22
AMCP Logo

August 2022 News & Views

August 2022 News & Views: Quarterly Strategic Priorities Update; Get Inspired by AMCP Nexus 2022 Keynote Sessions; Reducing Health Disparities: Exploring How ImplicitBias Influences Health Care; AMCP Board Approves New Where We StandStatement.

8/10/22
AMCP Logo

Hemophilia B Gene Therapy Pre-Approval Information Exchange

The Hemophilia B Gene Therapy Preapproval Information Exchange will provide information as it relates to etranacogene dezaparvovec, an investigational therapy that has not been approved by the US Food and Drug Association (FDA) for any use. Safety and effectiveness have not been established. This prepapproval information exchange has been prepared in accordance with FDA guidance for industry on communications with payers, formulary committees, or similar entities.